Ketogenic diet improves NAFLD, fibrosis in patients with type 2 diabetes

Comprehensive continuous care intervention with a ketogenic diet significantly improved surrogate markers of nonalcoholic fatty liver disease and advanced fibrosis in patients with type 2 diabetes after 1 year, according to data published in BMJ Open.
Eduardo Vilar-Gomez, MD, PhD, from the Indiana University School of Medicine, and colleagues wrote that low-carbohydrate, high-fat and ketogenic diets have demonstrated significant weight loss effects in adults with overweight and obesity. In the short-term, these diets have also correlated with improved insulin sensitivity and glycemic control.

Source link

Related posts

Maximizing precision and accuracy of the doubly labeled water method via optimal sampling protocol, calculation choices, and incorporation of 17O measurements


Resveratrol, lunularin and dihydroresveratrol do not act as caloric restriction mimetics when administered intraperitoneally in mice


Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World